A detailed history of Carroll Investors, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Carroll Investors, Inc holds 228 shares of LLY stock, worth $179,964. This represents 0.13% of its overall portfolio holdings.

Number of Shares
228
Holding current value
$179,964
% of portfolio
0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $176,047 - $218,884
228 New
228 $201,000
Q2 2022

Jul 26, 2022

SELL
$278.73 - $327.27 $20,347 - $23,890
-73 Closed
0 $0
Q4 2021

Feb 16, 2022

BUY
$224.85 - $279.04 $16,414 - $20,369
73 New
73 $20,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $750B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Carroll Investors, Inc Portfolio

Follow Carroll Investors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carroll Investors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Carroll Investors, Inc with notifications on news.